Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.
Identifieur interne : 006E58 ( Ncbi/Merge ); précédent : 006E57; suivant : 006E59Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.
Auteurs : Noriki Fujimoto [Japon] ; Mariko Mitsuru ; Toshihiro TanakaSource :
- Acta dermato-venereologica [ 1651-2057 ] ; 2015.
Descripteurs français
- KwdFr :
- Biopsie, Calendrier d'administration des médicaments, Dermatoses faciales (diagnostic), Dermatoses faciales (immunologie), Dermatoses faciales (traitement médicamenteux), Facteurs temps, Humains, Immunohistochimie, Lymphoedème (diagnostic), Lymphoedème (immunologie), Lymphoedème (traitement médicamenteux), Marqueurs biologiques (analyse), Mastocytes (), Mastocytes (immunologie), Minocycline (administration et posologie), Mâle, Résultat thérapeutique, Sujet âgé, Érythème (diagnostic), Érythème (immunologie), Érythème (traitement médicamenteux).
- MESH :
- administration et posologie : Minocycline.
- analyse : Marqueurs biologiques.
- diagnostic : Dermatoses faciales, Lymphoedème, Érythème.
- immunologie : Dermatoses faciales, Lymphoedème, Mastocytes, Érythème.
- traitement médicamenteux : Dermatoses faciales, Lymphoedème, Érythème.
- Biopsie, Calendrier d'administration des médicaments, Facteurs temps, Humains, Immunohistochimie, Mastocytes, Mâle, Résultat thérapeutique, Sujet âgé.
English descriptors
- KwdEn :
- Aged, Biomarkers (analysis), Biopsy, Drug Administration Schedule, Erythema (diagnosis), Erythema (drug therapy), Erythema (immunology), Facial Dermatoses (diagnosis), Facial Dermatoses (drug therapy), Facial Dermatoses (immunology), Humans, Immunohistochemistry, Lymphedema (diagnosis), Lymphedema (drug therapy), Lymphedema (immunology), Male, Mast Cells (drug effects), Mast Cells (immunology), Minocycline (administration & dosage), Time Factors, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Minocycline.
- chemical , analysis : Biomarkers.
- diagnosis : Erythema, Facial Dermatoses, Lymphedema.
- drug effects : Mast Cells.
- drug therapy : Erythema, Facial Dermatoses, Lymphedema.
- immunology : Erythema, Facial Dermatoses, Lymphedema, Mast Cells.
- Aged, Biopsy, Drug Administration Schedule, Humans, Immunohistochemistry, Male, Time Factors, Treatment Outcome.
DOI: 10.2340/00015555-1954
PubMed: 25510871
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001132
- to stream PubMed, to step Curation: 001132
- to stream PubMed, to step Checkpoint: 001132
Links to Exploration step
pubmed:25510871Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.</title><author><name sortKey="Fujimoto, Noriki" sort="Fujimoto, Noriki" uniqKey="Fujimoto N" first="Noriki" last="Fujimoto">Noriki Fujimoto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, Japan. noriki@belle.shiga-med.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192</wicri:regionArea><wicri:noRegion>Shiga 520-2192</wicri:noRegion></affiliation></author><author><name sortKey="Mitsuru, Mariko" sort="Mitsuru, Mariko" uniqKey="Mitsuru M" first="Mariko" last="Mitsuru">Mariko Mitsuru</name></author><author><name sortKey="Tanaka, Toshihiro" sort="Tanaka, Toshihiro" uniqKey="Tanaka T" first="Toshihiro" last="Tanaka">Toshihiro Tanaka</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25510871</idno><idno type="pmid">25510871</idno><idno type="doi">10.2340/00015555-1954</idno><idno type="wicri:Area/PubMed/Corpus">001132</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001132</idno><idno type="wicri:Area/PubMed/Curation">001132</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001132</idno><idno type="wicri:Area/PubMed/Checkpoint">001132</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001132</idno><idno type="wicri:Area/Ncbi/Merge">006E58</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.</title><author><name sortKey="Fujimoto, Noriki" sort="Fujimoto, Noriki" uniqKey="Fujimoto N" first="Noriki" last="Fujimoto">Noriki Fujimoto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, Japan. noriki@belle.shiga-med.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192</wicri:regionArea><wicri:noRegion>Shiga 520-2192</wicri:noRegion></affiliation></author><author><name sortKey="Mitsuru, Mariko" sort="Mitsuru, Mariko" uniqKey="Mitsuru M" first="Mariko" last="Mitsuru">Mariko Mitsuru</name></author><author><name sortKey="Tanaka, Toshihiro" sort="Tanaka, Toshihiro" uniqKey="Tanaka T" first="Toshihiro" last="Tanaka">Toshihiro Tanaka</name></author></analytic><series><title level="j">Acta dermato-venereologica</title><idno type="eISSN">1651-2057</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Biomarkers (analysis)</term><term>Biopsy</term><term>Drug Administration Schedule</term><term>Erythema (diagnosis)</term><term>Erythema (drug therapy)</term><term>Erythema (immunology)</term><term>Facial Dermatoses (diagnosis)</term><term>Facial Dermatoses (drug therapy)</term><term>Facial Dermatoses (immunology)</term><term>Humans</term><term>Immunohistochemistry</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (immunology)</term><term>Male</term><term>Mast Cells (drug effects)</term><term>Mast Cells (immunology)</term><term>Minocycline (administration & dosage)</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Biopsie</term><term>Calendrier d'administration des médicaments</term><term>Dermatoses faciales (diagnostic)</term><term>Dermatoses faciales (immunologie)</term><term>Dermatoses faciales (traitement médicamenteux)</term><term>Facteurs temps</term><term>Humains</term><term>Immunohistochimie</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (immunologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Marqueurs biologiques (analyse)</term><term>Mastocytes ()</term><term>Mastocytes (immunologie)</term><term>Minocycline (administration et posologie)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Érythème (diagnostic)</term><term>Érythème (immunologie)</term><term>Érythème (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Minocycline</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Biomarkers</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Minocycline</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Marqueurs biologiques</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Erythema</term><term>Facial Dermatoses</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Dermatoses faciales</term><term>Lymphoedème</term><term>Érythème</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Mast Cells</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Erythema</term><term>Facial Dermatoses</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Dermatoses faciales</term><term>Lymphoedème</term><term>Mastocytes</term><term>Érythème</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Erythema</term><term>Facial Dermatoses</term><term>Lymphedema</term><term>Mast Cells</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Dermatoses faciales</term><term>Lymphoedème</term><term>Érythème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Biopsy</term><term>Drug Administration Schedule</term><term>Humans</term><term>Immunohistochemistry</term><term>Male</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Biopsie</term><term>Calendrier d'administration des médicaments</term><term>Facteurs temps</term><term>Humains</term><term>Immunohistochimie</term><term>Mastocytes</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25510871</PMID><DateCreated><Year>2015</Year><Month>03</Month><Day>10</Day></DateCreated><DateCompleted><Year>2015</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1651-2057</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta dermato-venereologica</Title><ISOAbbreviation>Acta Derm. Venereol.</ISOAbbreviation></Journal><ArticleTitle>Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.</ArticleTitle><Pagination><MedlinePgn>368-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2340/00015555-1954</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujimoto</LastName><ForeName>Noriki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, Japan. noriki@belle.shiga-med.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsuru</LastName><ForeName>Mariko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Toshihiro</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Acta Derm Venereol</MedlineTA><NlmUniqueID>0370310</NlmUniqueID><ISSNLinking>0001-5555</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>FYY3R43WGO</RegistryNumber><NameOfSubstance UI="D008911">Minocycline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004890" MajorTopicYN="N">Erythema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005148" MajorTopicYN="N">Facial Dermatoses</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008911" MajorTopicYN="N">Minocycline</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25510871</ArticleId><ArticleId IdType="doi">10.2340/00015555-1954</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Mitsuru, Mariko" sort="Mitsuru, Mariko" uniqKey="Mitsuru M" first="Mariko" last="Mitsuru">Mariko Mitsuru</name><name sortKey="Tanaka, Toshihiro" sort="Tanaka, Toshihiro" uniqKey="Tanaka T" first="Toshihiro" last="Tanaka">Toshihiro Tanaka</name></noCountry><country name="Japon"><noRegion><name sortKey="Fujimoto, Noriki" sort="Fujimoto, Noriki" uniqKey="Fujimoto N" first="Noriki" last="Fujimoto">Noriki Fujimoto</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006E58 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 006E58 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:25510871
|texte= Successful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25510871" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |